Non-Polio enterovirus infections cost-effectiveness of therapy: Difference between revisions

Jump to navigation Jump to search
Aarti Narayan (talk | contribs)
No edit summary
Aarti Narayan (talk | contribs)
No edit summary
Line 2: Line 2:
{{Non-Polio enterovirus infections}}
{{Non-Polio enterovirus infections}}
{{CMG}}
{{CMG}}


Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.

Revision as of 20:33, 14 December 2012

Non-Polio enterovirus infections Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Non-Polio enterovirus infections from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Non-Polio enterovirus infections cost-effectiveness of therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Non-Polio enterovirus infections cost-effectiveness of therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Non-Polio enterovirus infections cost-effectiveness of therapy

CDC on Non-Polio enterovirus infections cost-effectiveness of therapy

Non-Polio enterovirus infections cost-effectiveness of therapy in the news

Blogs on Non-Polio enterovirus infections cost-effectiveness of therapy

Directions to Hospitals Treating Non-Polio enterovirus infections

Risk calculators and risk factors for Non-Polio enterovirus infections cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

The health care costs from enterovirus infections are unknown, but a large portion of the costs may come from use of over-the-counter medications to treat symptoms for millions of cases of "summer colds" and "flu" caused by enteroviruses. There are also significant costs associated with the 25,000 to 50,000 hospitalizations for aseptic meningitis each year in the United States.

References


Template:WikiDoc Sources